The objective of the present study was to analyse the association betw
een cigarette smoking and progression of retinopathy and nephropathy,
respectively, in a prospective multicentre study including 636 people
with Type 1 diabetes: 81 % of the original cohort of consecutively ref
erred patients, aged 15 to 40 years and free of severe late diabetic c
omplications. At baseline, all patients had participated in a 5-day in
-patient group treatment and teaching programme for intensification of
insulin therapy. Patients were examined at recruitment, and after 1,
2, 3 and 6 years including assessment of smoking status, blood pressur
e, metabolic control, and degree of nephropathy. Degree of retinopathy
was assessed by ophthalmoscopy or fundus photography at baseline and
after 6 years. Several logistic regression analyses were performed by
describing the responses retinopathy and nephropathy, respectively, ei
ther as progression yes/no or as actual status at the 6-year follow-up
and by using different measures for smoking. Adjustments for importan
t covariables were made. While significant associations between smokin
g, and retinopathy and nephropathy respectively, were found, the relat
ions were variable depending on the statistical model used. The result
s show that the real associations between smoking and retinopathy and
nephropathy are complex and that more emphasis should be put on the co
mplete description of the response variables and the statistical model
s used in clinical and epidemiological research.